DK0923550T3 - Acylaminoalkylen-amid-derivater som NK1- og NK2-antagonister - Google Patents

Acylaminoalkylen-amid-derivater som NK1- og NK2-antagonister

Info

Publication number
DK0923550T3
DK0923550T3 DK97918984T DK97918984T DK0923550T3 DK 0923550 T3 DK0923550 T3 DK 0923550T3 DK 97918984 T DK97918984 T DK 97918984T DK 97918984 T DK97918984 T DK 97918984T DK 0923550 T3 DK0923550 T3 DK 0923550T3
Authority
DK
Denmark
Prior art keywords
acylaminoalkylene
antagonists
amide derivatives
amide
derivatives
Prior art date
Application number
DK97918984T
Other languages
Danish (da)
English (en)
Inventor
Marc Gerspacher
Sprecher Andreas Von
Robert Mah
Silvio Roggo
Stefan Stutz
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of DK0923550T3 publication Critical patent/DK0923550T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an alkyl or cycloalkyl radical attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/12Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK97918984T 1996-08-22 1997-08-13 Acylaminoalkylen-amid-derivater som NK1- og NK2-antagonister DK0923550T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH206196 1996-08-22
PCT/EP1997/004436 WO1998007694A1 (en) 1996-08-22 1997-08-13 Acylaminoalkenylene-amide derivatives as nk1 and nk2 antagonists

Publications (1)

Publication Number Publication Date
DK0923550T3 true DK0923550T3 (da) 2003-01-06

Family

ID=4225003

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97918984T DK0923550T3 (da) 1996-08-22 1997-08-13 Acylaminoalkylen-amid-derivater som NK1- og NK2-antagonister

Country Status (32)

Country Link
US (1) US6319917B1 (es)
EP (1) EP0923550B1 (es)
JP (1) JP3654908B2 (es)
KR (1) KR100467402B1 (es)
CN (1) CN1119328C (es)
AR (1) AR009266A1 (es)
AT (1) ATE224875T1 (es)
AU (1) AU721850B2 (es)
BR (1) BR9711350A (es)
CA (1) CA2264065C (es)
CO (1) CO4900047A1 (es)
CZ (1) CZ294233B6 (es)
DE (1) DE69715886T2 (es)
DK (1) DK0923550T3 (es)
ES (1) ES2184083T3 (es)
HK (1) HK1021372A1 (es)
HU (1) HU226395B1 (es)
ID (1) ID18059A (es)
IL (1) IL128631A (es)
MY (1) MY132550A (es)
NO (1) NO312292B1 (es)
NZ (1) NZ334736A (es)
PE (1) PE107498A1 (es)
PL (1) PL193731B1 (es)
PT (1) PT923550E (es)
RU (1) RU2185375C2 (es)
SI (1) SI0923550T1 (es)
SK (1) SK283991B6 (es)
TR (1) TR199900363T2 (es)
TW (1) TW438777B (es)
WO (1) WO1998007694A1 (es)
ZA (1) ZA977493B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6281300B1 (en) * 1998-03-20 2001-08-28 Exxon Chemical Patents, Inc. Continuous slurry polymerization volatile removal
GB0010958D0 (en) * 2000-05-05 2000-06-28 Novartis Ag Organic compounds
GB0203061D0 (en) * 2002-02-08 2002-03-27 Novartis Ag Organic compounds
GB0224788D0 (en) * 2002-10-24 2002-12-04 Novartis Ag Organic compounds
GB2394417A (en) * 2002-10-24 2004-04-28 Novartis Ag Solid dispersion comprising a piperidine substance P antagonist and a carrier
BRPI0415923A (pt) * 2003-10-27 2006-12-26 Novartis Ag uso de antagonistas de neuroquinina no tratamento de incontigência urinária
DK1691814T3 (da) * 2003-12-01 2012-10-29 Cambridge Entpr Ltd Antiinflammatoriske midler
GB0402679D0 (en) * 2004-02-06 2004-03-10 Novartis Ag Organic compounds
GB0607532D0 (en) * 2006-04-13 2006-05-24 Novartis Ag Organic compounds
JO2630B1 (en) * 2006-04-13 2012-06-17 نوفارتيس ايه جي Organic compounds
EP1938804A1 (en) * 2006-12-22 2008-07-02 Novartis AG Pharmaceutical formulation comprising neurokinin antagonist
JP2010516734A (ja) 2007-01-24 2010-05-20 グラクソ グループ リミテッド 3,5−ジアミノ−6−(2,3−ジクロロフェニル)−1,2,4−トリアジンまたはr(−)−2,4−ジアミノ−5−(2,3−ジクロロフェニル)−6−フルオロメチルピリミジンを含む医薬組成物
UA105182C2 (ru) 2008-07-03 2014-04-25 Ньюрексон, Інк. Бензоксазины, бензотиазины и родственные соединения, которые имеют ингибирующую nos активность
EP2400953A1 (en) * 2009-02-24 2012-01-04 Novartis AG Uses of nk receptor antagonists
RU2697414C1 (ru) * 2018-05-11 2019-08-14 Общество с ограниченной ответственностью "АЙ БИ ДИ Терапевтикс" Новый антагонист тахикининовых рецепторов и его применение

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2110514A1 (en) 1991-07-05 1993-01-21 Raymond Baker Aromatic compounds, pharmaceutical compositions containing them and their use in therapy
MY110227A (en) * 1991-08-12 1998-03-31 Ciba Geigy Ag 1-acylpiperindine compounds.
US5217996A (en) 1992-01-22 1993-06-08 Ciba-Geigy Corporation Biaryl substituted 4-amino-butyric acid amides
EP0716077A1 (de) * 1994-12-08 1996-06-12 Ciba-Geigy Ag Aromatisch substituierte Omega-Aminoalkansäureamide und Alkansäurediamide und ihre Verwendung als Renininhibitoren
AU701560B2 (en) * 1995-02-22 1999-01-28 Novartis Ag 1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists

Also Published As

Publication number Publication date
NO312292B1 (no) 2002-04-22
CA2264065A1 (en) 1998-02-26
CZ58199A3 (cs) 1999-06-16
EP0923550A1 (en) 1999-06-23
HU226395B1 (en) 2008-11-28
DE69715886D1 (de) 2002-10-31
NO990786L (no) 1999-03-25
ZA977493B (en) 1998-08-03
KR20000068325A (ko) 2000-11-25
PL193731B1 (pl) 2007-03-30
ES2184083T3 (es) 2003-04-01
AU721850B2 (en) 2000-07-13
CA2264065C (en) 2008-02-05
SK283991B6 (sk) 2004-07-07
US6319917B1 (en) 2001-11-20
ATE224875T1 (de) 2002-10-15
SK22199A3 (en) 2000-02-14
BR9711350A (pt) 1999-08-17
HUP0001165A3 (en) 2002-02-28
RU2185375C2 (ru) 2002-07-20
TR199900363T2 (xx) 1999-04-21
EP0923550B1 (en) 2002-09-25
PL331740A1 (en) 1999-08-02
ID18059A (id) 1998-02-26
HUP0001165A2 (hu) 2000-11-28
KR100467402B1 (ko) 2005-01-24
NO990786D0 (no) 1999-02-19
CN1119328C (zh) 2003-08-27
AR009266A1 (es) 2000-04-12
WO1998007694A1 (en) 1998-02-26
CZ294233B6 (cs) 2004-11-10
CO4900047A1 (es) 2000-03-27
PE107498A1 (es) 1999-01-28
JP3654908B2 (ja) 2005-06-02
PT923550E (pt) 2003-01-31
TW438777B (en) 2001-06-07
SI0923550T1 (en) 2003-02-28
IL128631A0 (en) 2000-01-31
MY132550A (en) 2007-10-31
CN1233238A (zh) 1999-10-27
AU4299397A (en) 1998-03-06
JP2001503387A (ja) 2001-03-13
HK1021372A1 (en) 2000-06-09
NZ334736A (en) 2000-09-29
DE69715886T2 (de) 2003-05-15
IL128631A (en) 2002-09-12

Similar Documents

Publication Publication Date Title
FI970310A (fi) 4-indolijohdannaiset serotoniinin vaikuttaja- ja vastavaikuttaja-aineina
DE69729947T2 (de) N-substituierte 2-cyanopyrrolidine
FI964712A0 (fi) Kinoliinijohdannaisia takykiniini NK3-reseptoriantagonisteina
FI971685A (fi) Takykiniini-antagonisteja
NO994906D0 (no) GnRH antagonister som er modifisert i stillinger 5 og 6
DE59601122D1 (de) N-(Benzofurazanyl)-Arylsulfonamide und ihre Analoge verwendbar als Endothelin-Rezeptor-Antagonisten
ATE314387T1 (de) Dolastatin 15 derivate
DK0923550T3 (da) Acylaminoalkylen-amid-derivater som NK1- og NK2-antagonister
DK0871623T3 (da) 3-Azetinidylalkylpiperidiner eller -pyrrolidiner som tachykininantagonister
AU1667500A (en) N-(2-phenyl-4-piperidinybutyl)-5,6,7,8-tetrahydro-1-naphthal necarboxamides and their use as neurokinin 1 (nk1) and/or neurokinin 2 (nk2) receptor antagonists
DK0964863T3 (da) Oxazolidinoner som 5-HT2A-antagonister
NO985970D0 (no) Indolinderivater anvendelige som 5_HT-2C-reseptor-antagonister
ATE269072T1 (de) Synergistische kombination von nk1-rezeptor antagonisten und gaba analogen
NO992066D0 (no) Piperazinoderivater som neurokininantagonister
PT964867E (pt) Antagonistas da taquicinima
FI943513A (fi) Kolekystokiniiniantagonisteina käyttökelpoisia 3-fenyyliureidoatsepin-2-oneja ja -bentsatsepin-2-oneja
DE69709802D1 (de) Amythiamicin Amid-Derivate
ID26508A (id) Oksim-oksim tersubstitusi sebagai antagonis-antagonis neurokinin
DK0964867T3 (da) Tachykininantagonister
FI941117A0 (fi) Bentsyyli-imidatsopyridiinijohdannaiset angiotensiini II reseptoriantagonisteina